{"id":18892,"date":"2021-04-30T16:20:28","date_gmt":"2021-04-30T20:20:28","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=18892"},"modified":"2021-04-30T16:22:35","modified_gmt":"2021-04-30T20:22:35","slug":"ipo-weekly-summary-endeavor-launches-higher-in-debut","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-weekly-summary-endeavor-launches-higher-in-debut\/","title":{"rendered":"IPO Weekly Summary: Endeavor launches higher in debut"},"content":{"rendered":"

\"\"<\/a><\/p>\n

\n

Seven IPOs were on the schedule for this week, however, only six debuted. The most high-profile deal of the group, Endeavor Holdings Group (EDR), debuted with strength and followed through with solid aftermarket action on day two.<\/p>\n

Endeavor Group Holdings Inc (EDR)<\/strong> priced a full-size deal, 21.3mm shares, at $24.00 (high-end of the range) and opened at $27.00 for a gain of 12.5% at first trade. EDR, which owns the UFC, traded with increased volatility on day one. The stock broke its $24.00 issue price briefly before closing its opening session at $25.20. As previously mentioned, Endeavor traded well during its second session and closed the week at $27.56 or 14.3% above the issue price.<\/strong><\/p>\n

The best performing deal of the week came from the healthcare space. Technology-driven, national physician-enablement company, Privia Health Group, Inc. (PRVA)<\/strong> priced a full-size deal, 19.5mm shares, at $23.00 (high-end of upwardly-revised range) and opened at $30.00 for a gain of 30.4% at first trade. PRVA\u00a0<\/strong>closed its opening session at $34.75 and traded even higher in its second session and closed the week at $36.32 or 58% above the issue price.<\/strong><\/p>\n

The rest of the healthcare-related offerings had a mixed bag.<\/p>\n

Aveanna Healthcare Holdings Inc (AVAH)<\/strong> priced a full-size deal, 38.2mm shares, at $12.00 (low-end of the downwardly-revised range) and opened at $12.00. The stock immediately broke and traded the majority of the week below issue.<\/p>\n

Both biotech IPOs traded below issue on their first week, albeit the Werewolf Therapeutics did just briefly.<\/p>\n

Werewolf Therapeutics Inc (HOWL)<\/strong> priced 7.5mm shares (upsized from 6.25mm) at $16.00 (midpoint of the range) and opened at $18.21 for a gain of 13.8% at first trade. The stock traded wildly in its Friday debut session…hitting as high as $23.99 and as low as $15.59 before closing at $16.10 — slightly above the issue price.<\/p>\n

Vaccitech plc (VACC)\u00a0<\/strong>priced a full-size deal,\u00a06.5mm ADSs, at $17.00<\/strong>\u00a0(midpoint of the range) and\u00a0opened at $13.62 for a loss of 19.9% at first trade.<\/strong><\/p>\n

The lone energy deal of the week, FTC Solar, Inc. (FTCI) <\/strong>priced\u00a019.8mm shares\u00a0<\/strong>(upsized from 18.4mm) at\u00a0$13.00\u00a0<\/strong>($5 Below the $18-$20 Range) and\u00a0 opened at $15.21 for a gain of 17% at first trade.\u00a0<\/strong>The deep discount proved to be enough to get the stock out the door with a win.<\/p>\n

The lone IPO to fail to get out the door was specialty insurer, The Fortegra Grou<\/strong>p, which saw its deal postpone due to market conditions.<\/p>\n

Looking ahead to this week, there are currently six IPOs on the schedule.<\/p>\n

Wednesday (5\/5) Debut<\/strong><\/span><\/p>\n